IWATE MEDICAL UNIVERSITY
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Private
- Established
- 1901-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.iwate-med.ac.jp
Clinical Trials
76
Active:0
Completed:48
Trial Phases
5 Phases
Phase 1:4
Phase 2:5
Phase 3:1
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (73 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
62 (84.9%)Phase 2
5 (6.8%)Phase 1
4 (5.5%)Phase 3
1 (1.4%)Phase 4
1 (1.4%)Comparison of MECHANISM of Early and Late Vascular Responses Following Treatment of ST-elevation Acute Myocardial Infarction With Two Different Everolimus-eluting Stents: Randomized Controlled Trial Between Biodegradable Polymer and Durable Polymer Stent (MECHANISM-AMI-RCT)
Not Applicable
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2018-11-01
- Last Posted Date
- 2020-06-02
- Lead Sponsor
- Iwate Medical University
- Target Recruit Count
- 120
- Registration Number
- NCT03726892
- Locations
- π―π΅
Iwate Medical University Hospital, Morioka, Japan
Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN studIeS for TreatMent of Acute Myocardial InfarctionTreatment of ST-elevation Acute Myocardial Infarction
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2013-12-18
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Iwate Medical University
- Target Recruit Count
- 100
- Registration Number
- NCT02014753
- Locations
- π―π΅
Iwate Medical University Hospital, Morioka, Japan
Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant Chemotherapy
- Conditions
- Gastric Cancer
- First Posted Date
- 2013-07-23
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Iwate Medical University
- Target Recruit Count
- 500
- Registration Number
- NCT01905969
- Locations
- π―π΅
Iwate Medical University School of Medicine, Morioka, Iwate, Japan
Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma
Phase 1
Completed
- Conditions
- Renal Cell Carcinoma
- First Posted Date
- 2010-12-07
- Last Posted Date
- 2010-12-07
- Lead Sponsor
- Iwate Medical University
- Registration Number
- NCT01254838
Novel Peptide Vaccination for Patients With Advanced Prostate Cancer
Phase 1
- Conditions
- Prostate Cancer
- First Posted Date
- 2010-10-21
- Last Posted Date
- 2011-06-23
- Lead Sponsor
- Iwate Medical University
- Target Recruit Count
- 30
- Registration Number
- NCT01225471
- Locations
- π―π΅
Iwate Medical University School of Medicine, Morioka, Iwate, Japan
- Prev
- 1
- 2
- Next
News
No news found